Skip to content
10-Q

Quarterly Report

MEDICINES CO /DE

0001113481-19-000015

← back to feed
Filed
Apr 26, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2019 · Apr 22, 2019 73.9M sh
Shares Diluted Q1 2019 · Mar 31, 2019 74.46M sh
Shares Diluted Q1 2019 · Mar 31, 2018 73.8M sh
Capex Q1 2019 · Mar 31, 2019 $0
Capex Q1 2019 · Mar 31, 2018 $7K
Operating Cash Flow Q1 2019 · Mar 31, 2019 −$49.82M
Operating Cash Flow Q1 2019 · Mar 31, 2018 −$109.32M
Short Term Investments Q1 2019 · Mar 31, 2019 $2.35M
Short Term Investments Q1 2019 · Dec 31, 2018 $2.63M
Cash And Equivalents Q1 2019 · Mar 31, 2019 $199.74M
Cash And Equivalents Q1 2019 · Dec 31, 2018 $238.31M
Cash And Equivalents Q1 2019 · Mar 31, 2018 $215.96M
Stockholders Equity Q1 2019 · Mar 31, 2019 −$75.39M
Stockholders Equity Q1 2019 · Dec 31, 2018 −$22.26M
Current Liabilities Q1 2019 · Mar 31, 2019 $63.15M
Current Liabilities Q1 2019 · Dec 31, 2018 $58.41M
Total Liabilities Q1 2019 · Mar 31, 2019 $911.24M
Total Liabilities Q1 2019 · Dec 31, 2018 $863.95M
Current Assets Q1 2019 · Mar 31, 2019 $258.1M
Current Assets Q1 2019 · Dec 31, 2018 $294.8M
Total Assets Q1 2019 · Mar 31, 2019 $835.85M
Total Assets Q1 2019 · Dec 31, 2018 $841.69M
Eps Diluted Q1 2019 · Mar 31, 2019 −$0.80
Eps Diluted Q1 2019 · Mar 31, 2018 $0.39
Eps Basic Q1 2019 · Mar 31, 2019 −$0.80
Eps Basic Q1 2019 · Mar 31, 2018 $0.39
Sga Expense Q1 2019 · Mar 31, 2019 $16.98M
Sga Expense Q1 2019 · Mar 31, 2018 $28.95M
Rd Expense Q1 2019 · Mar 31, 2019 $27.01M
Rd Expense Q1 2019 · Mar 31, 2018 $40.37M
Net Income Q1 2019 · Mar 31, 2019 −$59.87M
Net Income Q1 2019 · Mar 31, 2018 $29.15M
Operating Income Q1 2019 · Mar 31, 2019 −$43.99M
Operating Income Q1 2019 · Mar 31, 2018 −$64.28M
Cost Of Revenue Q1 2019 · Mar 31, 2019 $0
Cost Of Revenue Q1 2019 · Mar 31, 2018 $2.74M
Revenue Q1 2019 · Mar 31, 2019 $0
Revenue Q1 2019 · Mar 31, 2018 $7.77M